ARCHIVES

Bush Appoints Kripke To President’s Cancer Panel

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

January 25, 2002

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

February 17, 2006

Scatter Radiation from Mammography Presents No Increased Cancer Risk

December 28, 2012

Appreciation: Quack-Buster Saul Green Used Science to Debunk Alternative Medicine Claims.

July 13, 2007

ACCC To Present Program On Impact Of New Technology

January 23, 1981

In Brief: Forel Retires As Dana-Farber Director, Successor Is David Livingston; Benacerraf Plans Departure

July 5, 1991